170 related articles for article (PubMed ID: 6761908)
1. Comparison of in vitro pyrimethamine assays and in vivo response to sulphadoxine-pyrimethamine in Plasmodium falciparum from Papua New Guinea.
Lamont G; Darlow B
Trans R Soc Trop Med Hyg; 1982; 76(6):797-9. PubMed ID: 6761908
[TBL] [Abstract][Full Text] [Related]
2. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children in Papua New Guinea. I. Plasmodium falciparum.
Darlow B; Vrbova H; Gibney S; Jolley D; Stace J; Alpers M
Am J Trop Med Hyg; 1982 Jan; 31(1):1-9. PubMed ID: 7036764
[TBL] [Abstract][Full Text] [Related]
3. The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results.
Schapira A; Bygbjerg IC; Jepsen S; Flachs H; Bentzon MW
Am J Trop Med Hyg; 1986 Mar; 35(2):239-45. PubMed ID: 3513641
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro susceptibility of Plasmodium falciparum to sulphadoxine/pyrimethamine in Liberia, West Africa.
Björkman A; Willcox M
Trans R Soc Trop Med Hyg; 1986; 80(4):572-4. PubMed ID: 3544359
[TBL] [Abstract][Full Text] [Related]
5. In vivo assessment of the sensitivity of Plasmodium falciparum to sulphadoxine/pyrimethamine combination (Fansidar) in six localities in Tanzania where chloroquine-resistant P. falciparum has been detected.
Kilimali VA; Mkufya AR
Trans R Soc Trop Med Hyg; 1985; 79(4):482-3. PubMed ID: 3909553
[TBL] [Abstract][Full Text] [Related]
6. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children of Papua New Guinea. II. Plasmodium vivax.
Darlow B; Vrbova H; Gibney S; Jolley D; Stace J; Alpers M
Am J Trop Med Hyg; 1982 Jan; 31(1):10-3. PubMed ID: 7036765
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria.
Salako LA; Aderounmu AF; Laoye JO; Makinde JM; Adio RA
Ann Trop Med Parasitol; 1988 Aug; 82(4):325-30. PubMed ID: 3075441
[TBL] [Abstract][Full Text] [Related]
8. A case of fansidar-resistant Plasmodium falciparum from Tanzania.
De Geus A; Meuwissen JH; van Rijn A
Trop Geogr Med; 1982; 34(3):261-3. PubMed ID: 6758245
[No Abstract] [Full Text] [Related]
9. Comparative efficacy of alternative primary therapies for Plasmodium falciparum infections in Malawi.
Heymann DL; Khoromana CO; Wirima JJ; Campbell CC
Trans R Soc Trop Med Hyg; 1987; 81(5):722-4. PubMed ID: 3329780
[TBL] [Abstract][Full Text] [Related]
10. Development of an in vitro microtest for determining the susceptibility of Plasmodium falciparum to sulfadoxine-pyrimethamine: laboratory investigations and field studies in Port-au-Prince, Haiti.
Nguyen-Dinh P; Payne D; Teklehaimanot A; Zevallos-Ipenza A; Day MM; Duverseau YT
Bull World Health Organ; 1985; 63(3):585-92. PubMed ID: 3899394
[TBL] [Abstract][Full Text] [Related]
11. Efficacies of chloroquine and pyrimethamine-sulphadoxine in a Nigerian population with chloroquine resistant P. falciparum malaria.
Usanga EA; Ezedinachi EN; Gemade EI; Ikpatt NW; Alaribe AA
East Afr Med J; 1990 May; 67(5):295-301. PubMed ID: 2202586
[TBL] [Abstract][Full Text] [Related]
12. Response of Plasmodium falciparum to dihydrofolate reductase inhibitors in Malindi, Kenya.
Spencer HC; Watkins WW; Sixsmith DG; Koech DK
Trans R Soc Trop Med Hyg; 1986; 80(2):201-3. PubMed ID: 3538522
[TBL] [Abstract][Full Text] [Related]
13. Amodiaquine and sulfadoxine-pyrimethamine as treatment for chloroquine-resistant Plasmodium falciparum in Rwanda.
Deloron P; Sexton JD; Bugilimfura L; Sezibera C
Am J Trop Med Hyg; 1988 Mar; 38(2):244-8. PubMed ID: 3281489
[TBL] [Abstract][Full Text] [Related]
14. The in vivo sensitivity of Plasmodium falciparum to chloroquine and to sulphadoxine-pyrimethamine combination in Ibadan, Nigeria.
Olatunde A; Salako LA; Walker O
Trans R Soc Trop Med Hyg; 1981; 75(6):848-50. PubMed ID: 7036438
[TBL] [Abstract][Full Text] [Related]
15. [Unsuccessful effect of sulfadoxine-pyrimethamine in the treatment of falciparum malaria in Tanzania].
Vestergaard Olsen V
Ugeskr Laeger; 1983 Mar; 145(10):751. PubMed ID: 6344376
[No Abstract] [Full Text] [Related]
16. In vitro susceptibility of Plasmodium falciparum collected from pyrimethamine-sulfadoxine sensitive and resistant areas in Thailand.
Sabchareon A; Chongsuphajaisiddhi T; Attanath P; Kanjanapipatkul K; Doberstyn EB; Suebsaeng L
Bull World Health Organ; 1985; 63(3):597-602. PubMed ID: 3899396
[TBL] [Abstract][Full Text] [Related]
17. [In vivo resistance of Plasmodium falciparum to the combination of sulfadoxine and pyrimethamine, at RIII level, in Amazonas, Brazil].
Alecrim WD; Dourado H; Alecrim M das G; Passos LF; Wanssa E; Albuquerque B
Rev Inst Med Trop Sao Paulo; 1982; 24(6 Suppl):52-3. PubMed ID: 6764290
[No Abstract] [Full Text] [Related]
18. Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand.
Hurwitz ES; Johnson D; Campbell CC
Lancet; 1981 May; 1(8229):1068-70. PubMed ID: 6112445
[TBL] [Abstract][Full Text] [Related]
19. Fansidar resistant Plasmodium falciparum infection in Surinam.
Oostburg BF; Jozefzoon LM
Trop Geogr Med; 1983 Sep; 35(3):243-7. PubMed ID: 6359597
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
